Alliance for mRNA Medicines

It's been a busy year for AMM. Check out some of the highlights below then visit https://mrnamedicines.org to learn how you can become a member today!

A big thank you to all the sponsors and attendees who made AMM’s 1st Annual Meeting a smashing success. Planning is already underway for next year, so stay tuned for updates. Interested in becoming an AMM member? Visit https://mrnamedicines.org/ to learn more.

Learn from key regulators at AMM ASCENT! We’re thrilled to welcome FDA officials to AMM’s 1st annual meeting next week, including Peter Marks, Director of the Center for Biologics Evaluation and Research, and Julie Tierney, Deputy Center Director, who will share critical insights during our Regulatory Outlook session on Thursday, November 14. We’ll explore the FDA's latest perspectives on regulatory pathways for mRNA technologies, tackling challenges in platform technology, and discussing the future of mRNA-based therapies and vaccines. Don’t miss this opportunity to connect, learn, and collaborate with industry leaders dedicated to advancing the future of mRNA medicine It’s not too late to register! https://lnkd.in/e4JzQMf4

Ariel Kantor, PhD, from ReCode Therapeutics, presented “Selective Organ Targeting (SORT) Lipid Nanoparticle (LNP) Platform for Lung Delivery” at TIDES USA 2024 earlier this year. He also represented AMM at the conference in a plenary panel discussion on “mRNA Therapies - The Next Chapter.” Learn more in TIDES Global: https://lnkd.in/eS8SwYff Dr. Kantor will be a featured panelist in our “Investor Perspectives” discussion at AMM ASCENT, our 1st Annual Meeting, coming up next week in Boston. It's not too late to register! Visit https://lnkd.in/e4JzQMf4

Don't miss our "Investor Perspectives" panel at AMM ASCENT, our first annual meeting. Hear leading institutional investors share their insights and perspectives on what is driving their interest in mRNA technology. Featuring: ? Alan Colowick (Matrix Capital Management) ? Ariel Kantor, PhD (ReCode Therapeutics) ? Irina Margine, Ph.D. (Wellington Management) ? Ipsita Smolinski (Capitol Street) ? Edward Tenthoff (Piper Sandler) AMM ASCENT begins on Nov. 13 and registration closes soon! Learn more and register today: https://lnkd.in/e4JzQMf4

Earlier this week, Alliance for mRNA Medicines leaders, including Andy Geall, Ye Zhang, Bernard Sagaert, Thomas Langenickel, Phil Challis, and Sara Singleton, met with officials from the Medicines & Healthcare products Regulatory Agency?(MHRA) and European Medicines Agency (EMA) to introduce AMM and discuss the promise of mRNA vaccines and therapeutics. It is clear officials understand the potential of mRNA products to address the unmet needs of patients.?

The hotel deadline for AMM ASCENT, our first annual meeting, is coming up soon! Book your hotel reservation no later than this Friday, October 25 to take advantage of our group discount. Everyone in the mRNA community is welcome to attend AMM ASCENT, whether or not your organization is a member of the Alliance. And if you're already in Boston for the mRNA Health Conference, extend your stay to hear from our exciting group of speakers and presenters! Learn more and register at: https://lnkd.in/e4JzQMf4

Speaker Announcement Alert! We’re excited to reveal that some of the amazing speakers for AMM Ascent have been announced! Head over to our event page to check out who will be joining us in Boston this November to share their insights and expertise. Register today to secure your spot and explore the full agenda on our conference site! https://lnkd.in/e4JzQMf4 #AMMAscent #mRNAMedicines

?? Join the Future of mRNA Innovation at the 1st Annual Alliance for mRNA Medicines Meeting! ?? The Alliance for mRNA Medicines is hosting its 1st Annual Meeting, bringing together top innovators, researchers, and industry leaders to drive the next generation of mRNA therapies. This highly anticipated event will focus on: ? Expanding mRNA technology beyond vaccines to groundbreaking treatments ? Building partnerships to accelerate R&D across the healthcare ecosystem ? Navigating regulatory landscapes and funding opportunities to support the next wave of innovation To maximize collaboration and networking, the event will leverage partneringONE to simplify connecting with potential partners, investors, and collaborators. Attendees can efficiently schedule 1:1 meetings, accelerating opportunities for collaboration and growth. If you’re in the mRNA space, this is a must-attend event! Register now and be a part of the movement that’s shaping the future of medicine. Learn more: https://spr.ly/6048qGvMG ?? Save the date and connect through partneringONE! #MRNAMedicines #BiotechInnovation #partneringONE #Biopharma #LifeSciences #biotechnetworking #PowerUpYourPartnering #ConnectionsThatCount

We're excited to have Life Science Connect's Advancing RNA as a media partner for our first annual AMM ASCENT meeting. Visit Advancing RNA to follow Anna Rose Welch's "ARW on RNA," and to stay up-to-date on thought leadership from your peers via Advancing RNA's expert network of contributors.?https://lnkd.in/eae7SdBz